Reduced MOTS-c levels have been regarded as an early sign of mitochondrial dysfunction in a range of cardiovascular diseases, including heart failure 17, diabetic cardiomyopathy 41, and coronary artery disease 42. This evidence concerns the gene MT-RNR1 and cardiovascular disorder.